Published in Front Biosci on September 01, 2006
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab (2012) 3.81
Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med (2008) 1.50
Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res (2015) 1.08
Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro. Dig Dis Sci (2008) 0.96
Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. J Physiol (2012) 0.91
Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer. Front Endocrinol (Lausanne) (2014) 0.86
Activity of MMP1 and MMP13 and amino acid metabolism in patients with alcoholic liver cirrhosis. Med Sci Monit (2015) 0.80
Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach. Int J Mol Sci (2015) 0.79
Glutamine metabolism in advanced age. Nutr Rev (2016) 0.76
PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence. Oncotarget (2016) 0.76
Mitochondrial proteomics of the acetic acid - induced programmed cell death response in a highly tolerant Zygosaccharomyces bailii - derived hybrid strain. Microb Cell (2016) 0.75
Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells. Oncotarget (2016) 0.75
Beta-catenin in the liver: an integrator of proliferation and metabolism? Gastroenterology (2006) 0.75
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab (2012) 3.81
Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol (2008) 2.17
Oxidative stress in apoptosis and cancer: an update. Arch Toxicol (2012) 1.99
Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem J (2005) 1.76
Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur J Biochem (2004) 1.62
Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol (2002) 1.55
Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol (2009) 1.24
Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells. Glia (2009) 1.19
Expression of the scaffolding PDZ protein glutaminase-interacting protein in mammalian brain. J Neurosci Res (2008) 1.16
Nuclear localization of L-type glutaminase in mammalian brain. J Biol Chem (2002) 1.10
Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms. Free Radic Biol Med (2010) 1.10
Expression of functional human glutaminase in baculovirus system: affinity purification, kinetic and molecular characterization. Int J Biochem Cell Biol (2006) 1.08
Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells. J Cell Biochem (2008) 1.06
Genomic organization and transcriptional analysis of the human l-glutaminase gene. Biochem J (2003) 1.04
Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism. PLoS One (2012) 1.01
A novel glutaminase isoform in mammalian tissues. Neurochem Int (2009) 0.96
New insights into brain glutaminases: beyond their role on glutamatergic transmission. Neurochem Int (2009) 0.94
Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors. Psychopharmacology (Berl) (2011) 0.90
Glutaminase: a multifaceted protein not only involved in generating glutamate. Neurochem Int (2006) 0.89
Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells. J Mol Med (Berl) (2013) 0.88
Expression of recombinant human L-glutaminase in Escherichia coli: polyclonal antibodies production and immunological analysis of mouse tissues. Biochim Biophys Acta (2003) 0.85
Identification of genes downregulated in tumor cells expressing antisense glutaminase mRNA by differential display. Cancer Biol Ther (2006) 0.84
Differential prefrontal-like deficit in children after cerebellar astrocytoma and medulloblastoma tumor. Behav Brain Funct (2008) 0.82
Sulphur-containing non enzymatic antioxidants: therapeutic tools against cancer. Front Biosci (Schol Ed) (2012) 0.82
Inhibition of glutaminase expression increases Sp1 phosphorylation and Sp1/Sp3 transcriptional activity in Ehrlich tumor cells. Cancer Lett (2005) 0.81
Glutamine, glucose and other fuels for cancer. Curr Pharm Des (2014) 0.81
Sensitisation of Ehrlich ascitic tumour cells to methotrexate by inhibiting glutaminase. Anticancer Res (2005) 0.80
S-nitrosothiols regulate cell-surface pH buffering by airway epithelial cells during the human immune response to rhinovirus. Am J Physiol Lung Cell Mol Physiol (2006) 0.80
Expression of Gls and Gls2 glutaminase isoforms in astrocytes. Glia (2014) 0.79
Cocaine modulates both glutaminase gene expression and glutaminase activity in the brain of cocaine-sensitized mice. Psychopharmacology (Berl) (2011) 0.78
[Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project]. Med Clin (Barc) (2009) 0.78
Brain glutaminases. Biomol Concepts (2010) 0.77
Hemimegalencephaly: prenatal diagnosis and outcome. Fetal Diagn Ther (2011) 0.76
Declarative and procedural learning in children and adolescents with posterior fossa tumours. Behav Brain Funct (2006) 0.75
Pineal cysts. J Neurosurg Pediatr (2011) 0.75